[Interferonogenic and antiviral activity of the double-stranded replicative form of phage f2 RNA in tissue culture and on animals]. 1978

A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ

Biological activity of a new natural interferon inductor, the replicative RNA form of phage f2 (RFf2) was studied. A possibility of using RFf2 for production of highly active interferon under conditions of superinduction providing an increase in the interferon yield by to 256--512 times as compared to the control samples was shown. The protective interferonogenic and antiviral effect of RFf2 in mice infected with Semliki forest virus (SFV) and tickborne encephalitis virus (TBEV) was studied on administration of the inductor by various routes. It was found that intraperitoneal administration of RFf2 in a dose of 10 gamma per a mouse protected the infected animals from death. It was accompanied by production of up to 1280 units/ml of interferon in the blood serum of the animals. Maximum protection of the animals from death under conditions of the experiment (80 per cent on infection with SFV and 65 per cent on infection with TBEV) was observed when the preparation was administered twice: 4 hours after the infection. Combined use of RFf2 with chemotherapeutics (rimantadine) increased the protective effect both in the tissue culture and in vivo.

UI MeSH Term Description Entries
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D011070 Poly I-C Interferon inducer consisting of a synthetic, mismatched double-stranded RNA. The polymer is made of one strand each of polyinosinic acid and polycytidylic acid. Poly(I-C),Poly(rI).Poly(rC),Polyinosinic-Polycytidylic Acid,Polyinosinic-Polycytidylic Acid (High MW),Polyriboinosinic-Polyribocytidylic Acid,Polyribose Inosin-Cytidil,Inosin-Cytidil, Polyribose,Poly I C,Polyinosinic Polycytidylic Acid,Polyriboinosinic Polyribocytidylic Acid,Polyribose Inosin Cytidil
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000218 Adamantane A tricyclo bridged hydrocarbon. Diamantane
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000882 Haplorhini A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes). Anthropoidea,Monkeys,Anthropoids,Monkey
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001102 Arbovirus Infections Infections caused by arthropod-borne viruses, general or unspecified. Arbovirus Infection,Infection, Arbovirus,Infections, Arbovirus
D001103 Arboviruses Arthropod-borne viruses. A non-taxonomic designation for viruses that can replicate in both vertebrate hosts and arthropod vectors. Included are some members of the following families: ARENAVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; TOGAVIRIDAE; and FLAVIVIRIDAE. (From Dictionary of Microbiology and Molecular Biology, 2nd ed) Arbovirus,Arthropod-Borne Virus,Arthropod-Borne Viruses,Arthropod Borne Virus,Arthropod Borne Viruses,Virus, Arthropod-Borne,Viruses, Arthropod-Borne

Related Publications

A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ
April 1964, Proceedings of the National Academy of Sciences of the United States of America,
A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ
December 1983, General physiology and biophysics,
A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ
November 2012, Cell reports,
A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ
April 1976, Acta virologica,
A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ
March 1990, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ
April 1975, Acta virologica,
A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ
January 1977, Journal of hygiene, epidemiology, microbiology, and immunology,
A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ
November 2017, Cold Spring Harbor protocols,
A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ
June 2006, CSH protocols,
A A Kadyrova, and A N Fomina, and F I Ershov, and A S Novokhatskiĭ
October 1975, Virology,
Copied contents to your clipboard!